The Scientific Research and Development team at Foresight Diagnostics focuses on advancing liquid biopsy technologies to enhance the sensitivity and accuracy of cancer relapse detection. This interdisciplinary team conducts innovative research, develops and optimizes in-vitro diagnostic assays, and translates scientific findings into clinically applicable solutions, ensuring the continuous improvement of their minimal residual disease testing capabilities.
View all